2023-11-16 | Sale | Supernus Pharmaceuticals, Inc. SUPN | director | 2,500 0.0046% | $28.01 | $70,025 | +1.78% | |
2012-05-04 | Supernus Pharmaceuticals, Inc. SUPN | 4.4M 21.9118% | $5.00 | $22M | +29.48% | |||
2012-03-07 | Amicus Therapeutics, Inc. FOLD | 10 percent owner | 1.14M 3.1412% | $5.70 | $6.5M | -8.42% | ||
2008-03-10 | DZS Inc. DZSI | 10 percent owner | 100,000 0.0689% | $1.11 | $110,570 | -73.36% | ||
2008-03-07 | DZS Inc. DZSI | 10 percent owner | 84,250 0.0565% | $1.11 | $93,332 | -72.73% | ||
2008-03-06 | DZS Inc. DZSI | 10 percent owner | 80,083 0.054% | $1.10 | $88,388 | -72.48% | ||
2008-03-05 | DZS Inc. DZSI | 10 percent owner | 123,700 0.0815% | $1.08 | $133,274 | -72.48% | ||
2008-03-04 | DZS Inc. DZSI | 10 percent owner | 56,000 0.0389% | $1.07 | $60,172 | -70.39% | ||
2008-03-03 | DZS Inc. DZSI | 10 percent owner | 82,345 0.0548% | $1.10 | $90,522 | -71.82% | ||
2008-02-29 | DZS Inc. DZSI | 10 percent owner | 122,432 0.0841% | $1.11 | $136,316 | -69.44% | ||
2008-02-28 | DZS Inc. DZSI | 10 percent owner | 126,950 0.086% | $1.14 | $144,596 | -70.54% | ||
2008-02-27 | DZS Inc. DZSI | 10 percent owner | 126,950 0.0892% | $1.15 | $145,954 | -69.72% | ||
2008-02-26 | DZS Inc. DZSI | 10 percent owner | 25,205 0.0166% | $1.12 | $28,343 | -71.05% | ||
2008-02-25 | DZS Inc. DZSI | 10 percent owner | 71,950 0.0474% | $1.11 | $79,641 | -70.54% | ||
2008-02-22 | DZS Inc. DZSI | 10 percent owner | 130,200 0.0861% | $1.09 | $142,152 | -70% | ||
2008-02-21 | DZS Inc. DZSI | 10 percent owner | 47,660 0.0332% | $1.10 | $52,250 | -68.1% | ||
2008-02-20 | DZS Inc. DZSI | 10 percent owner | 50,691 0.033% | $1.06 | $53,514 | -68.52% | ||
2008-02-19 | DZS Inc. DZSI | 10 percent owner | 122,718 0.083% | $1.07 | $130,781 | -67.62% | ||
2008-02-15 | DZS Inc. DZSI | 10 percent owner | 61,722 0.0477% | $1.12 | $69,382 | -64.95% | ||
2008-02-14 | DZS Inc. DZSI | 10 percent owner | 114,300 0.0783% | $1.20 | $137,480 | -70.51% |